THANK YOU

Your Fairfax Membership account setup is complete. We are redirecting you now. Please use this email "      " to log in to the Financial Review in the future.

Try The Financial Review App on your Android Tablet

Do not show this message again
advertising

Pain drug developer Phosphagenics raises $19.3m

PUBLISHED: 11 Jul 2014 12:33:00 | UPDATED: 11 Jul 2014 12:34:54PRINT EDITION: 11 Jul 2014
Share Links:

Embattled drug delivery company Phosphagenics has raised $19.3 million to fund a clinical trial for its pain-management patches.

BY Jessica Gardner

advertising
advertising

Read more

Companies Phosphagenics Ltd
People Harry Rosen
Topics Health & Wellbeing, Pharmaceuticals & Healthcare Industry /Biotech & Pharmaceuticals

advertising